US2012203323A1PendingUtilityA1
Method and system for delivery of coated implants
Est. expiryApr 27, 2021(expired)· nominal 20-yr term from priority
A61L 29/085A61F 2210/0004A61F 2/82A61L 29/14A61F 2250/0067
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An implant delivery system comprises an implant delivery device having a releasable implant retention region, with the releasable implant retention region having a delivery device coating including a therapeutic agent. The implant delivery device may be a balloon catheter. An implant is releasably positioned in physical communication with the releasable implant retention region. The implant may comprise an implant coating on its inner and/or outer surface, and the implant coating may include a therapeutic agent. The implant may be a stent.
Claims
exact text as granted — not AI-modified1 .- 23 . (canceled)
24 . An implant delivery system comprising:
an implant delivery device having a distal end with a releasable implant retention region, the releasable implant retention region having an outer surface comprising a delivery device coating, said delivery device coating including a therapeutic agent; and a releasable implant releasably positioned in physical communication with the releasable implant retention region.
25 . The implant delivery system of claim 24 wherein the implant comprises an implant coating.
26 . The implant delivery system of claim 25 wherein the implant coating is positioned on an inner surface of the implant.
27 . The implant delivery system of claim 26 wherein the implant coating includes a therapeutic agent.
28 . The implant delivery system of claim 27 wherein the therapeutic agent comprises a vascular cell growth promoter.
29 . The implant delivery system of claim 25 wherein the implant coating is positioned on an outer surface of the implant.
30 . The implant delivery system of claim 29 wherein the implant coating includes a therapeutic agent.
31 . The implant delivery system of claim 30 wherein the therapeutic agent comprises an antiproliferative agent.
32 . The implant delivery system of claim 25 wherein the implant coating is positioned on an inner surface and an outer surface of the implant.
33 . The implant delivery system of claim 32 wherein the implant coating includes a therapeutic agent.
34 . The implant delivery system of claim 24 wherein the implant delivery device is a balloon catheter.
35 . The implant delivery system of claim 24 wherein the delivery device coating comprises an implant adhesion-resistant treatment.
36 . The implant delivery system of claim 35 wherein the implant adhesion-resistant treatment includes a non-adhesive silicone coating.
37 . The implant delivery system of claim 35 wherein the implant adhesion-resistant treatment includes a non-adhesive hydrophilic coating.
38 . The implant delivery system of claim 35 wherein the implant adhesion-resistant treatment includes a non-adhesive hydrogel coating.
39 . The implant delivery system of claim 35 wherein the implant adhesion-resistant treatment includes a non-adhesive carbowax coating.
40 . The implant delivery system of claim 35 wherein the implant adhesion-resistant treatment includes a non-adhesive PEO coating.
41 . The implant delivery system of claim 24 wherein the implant is a balloon-expandable stent.
42 . The implant delivery system of claim 24 wherein the implant is a self-expanding stent.
43 . The implant delivery system of claim 24 wherein said releasable implant retention region extends along an entire length of the implant.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.